ACTC1, or actin alpha cardiac muscle 1, is a critical protein primarily expressed in cardiac muscle cells. Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells. ACTC1, specifically, is a major component of the contractile apparatus in cardiac muscle cells, playing a vital role in the contraction and relaxation cycle of the heart. The proper functioning and regulation of ACTC1 are crucial for maintaining the rhythmic and coordinated contractions of the heart, ensuring efficient blood circulation throughout the body. Given its central role in cardiac muscle function, any disruption or modification in ACTC1's activity or expression can have significant consequences for heart health.
Inhibitors targeting ACTC1 would act to modulate the activity, stability, or interactions of this protein. Such inhibitors could affect the dynamics of cardiac muscle contraction by altering the interactions between ACTC1 and other proteins in the contractile machinery. Depending on their specific mode of action, these inhibitors could either enhance or reduce the contractile force of the heart. Furthermore, they might also influence the rate of muscle relaxation, which is equally important for efficient heart function. By modulating ACTC1 activity, these inhibitors could potentially alter the biomechanical properties of cardiac muscle cells, affecting their elasticity, stiffness, or response to mechanical stress. In the intricate and delicately balanced environment of the heart, where precise coordination of numerous proteins is essential, inhibitors of ACTC1 would need to be used with caution, ensuring that they do not inadvertently disrupt the overall balance of cardiac muscle function. Given the fundamental role of ACTC1 in cardiac physiology, any compounds that influence its function would be of considerable interest in the field of molecular cardiology, offering insights into the intricate workings of the cardiac contractile apparatus.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D binds to the barbed end of actin filaments, preventing their polymerization. This could indirectly impact the stability or dynamics of ACTC1. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds actin monomers and prevents their polymerization, potentially affecting ACTC1 dynamics. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Swinholide A severs actin filaments, which could influence the cellular dynamics of ACTC1. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and prevents their depolymerization, potentially affecting ACTC1 dynamics. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin binds and stabilizes actin filaments. Though used primarily as a staining agent, it impacts actin dynamics and may influence ACTC1. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
SMIFH2 is a formin inhibitor. Since formins are involved in actin nucleation, this could indirectly affect ACTC1 dynamics. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 is an Arp2/3 complex inhibitor, affecting branched actin dynamics, which might have an indirect impact on ACTC1. | ||||||
CK-869 | 388592-44-7 | sc-507274 | 5 mg | $163.00 | ||
CK-869 is an Arp2/3 complex inhibitor like CK-666, and may similarly influence ACTC1 indirectly. | ||||||